DOW JONES22,091.21+454.43 2.10%
S&P 5002,603.89+62.42 2.46%
NASDAQ7,718.38+216.00 2.88%

Wedbush Maintains Outperform on Albireo Pharma, Lowers Price Target to $60

Wedbush maintains Albireo Pharma (NASDAQ:ALBO) with a Outperform and lowers the price target from $69 to $60.

Benzinga · 03/03/2020 12:58

Wedbush maintains Albireo Pharma (NASDAQ:ALBO) with a Outperform and lowers the price target from $69 to $60.